New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures

Frontotemporal lobar degeneration (FTLD) is the most common form of dementia for those under 60 years of age. Increasing numbers of therapeutics targeting FTLD syndromes are being developed. Read & Research Alzheimer’s More

Leave a Reply